Biogen Inc
Change company Symbol lookup
Select an option...
BIIB Biogen Inc
GOVT iShares U.S. Treasury Bond ETF
BAC Bank of America Corp
$NQASPA50JPYN Nasdaq ASPA Industrials Net Total Re
SNP China Petroleum & Chemical Corp
GAEC Gulf Alternative Energy Corp
RDBX Redbox Entertainment Inc
AFG American Financial Group Inc
MRNA Moderna Inc
PFE Pfizer Inc
Go

Health Care : Biotechnology | Mid Cap Value
Company profile

Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company's marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions; GAZYVA indicated for the treatment of CLL and follicular lymphoma; OCREVUS for the treatment of primary progressive MS (PPMS) and relapsing MS (RMS), and other anti-CD20 therapies. The Company's pipeline includes BIIB074; BAN2401; BIIB061; BIIB067, BIIB124, BIIB074, BIIB118 and TMS-007.

Closing Price
$242.90
Day's Change
-7.23 (-2.89%)
Bid
--
Ask
--
B/A Size
--
Day's High
250.78
Day's Low
242.02
Volume
(Heavy Day)
Volume:
1,300,389

10-day average volume:
1,067,304
1,300,389
  • Prev Close
    250.13
  • Today's Open
    250.78
  • Day's Range
    242.02-250.78
  • Avg Vol (10-day)
    1.1M
  • Last (time)
    1:00p ET 11/26/21
  • Last (size)
    2
  • 52-Wk Range
    238.40 - 468.55
    LowHigh
  • (01/04/21 - 06/07/21)
    1.89%
  • 42.9%
  • Market Cap
    35.7B
  • Shares Outstanding
    146.9M
  • --
  • --x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • --
  • --

Latest News

November 24, 2021
4:40 pm ET
MarketWatch
November 23, 2021
4:40 pm ET
MarketWatch
November 22, 2021
4:40 pm ET
MarketWatch
November 19, 2021
4:40 pm ET
MarketWatch
8:49 am ET
MarketWatch
November 18, 2021
4:39 pm ET
MarketWatch
November 17, 2021
4:40 pm ET
MarketWatch
7:51 am ET
MarketWatch
7:41 am ET
MarketWatch
7:37 am ET
MarketWatch
7:30 am ET
Globe Newswire
November 16, 2021
4:39 pm ET
MarketWatch
9:20 am ET
Globe Newswire
8:50 am ET
PR Newswire
November 15, 2021
11:04 pm ET
Globe Newswire
4:40 pm ET
MarketWatch
7:30 am ET
Globe Newswire
November 12, 2021
4:40 pm ET
MarketWatch
November 11, 2021
5:10 pm ET
Globe Newswire
4:40 pm ET
MarketWatch
12:00 pm ET
PR Newswire
11:20 am ET
PR Newswire
November 10, 2021
4:39 pm ET
MarketWatch
2:57 pm ET
PR Newswire
November 09, 2021
4:40 pm ET
MarketWatch
November 08, 2021
4:40 pm ET
MarketWatch
November 05, 2021
4:40 pm ET
MarketWatch
November 04, 2021
4:40 pm ET
MarketWatch
November 03, 2021
4:40 pm ET
MarketWatch
7:30 am ET
Globe Newswire
November 02, 2021
4:40 pm ET
MarketWatch
November 01, 2021
4:40 pm ET
MarketWatch
October 29, 2021
4:40 pm ET
MarketWatch
October 28, 2021
4:40 pm ET
MarketWatch
October 27, 2021
4:40 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.